Australian study shows combined genomic screening for major hereditary diseases is cost-effective and health-saving

In an Australian study published in EClinicalMedicine, researchers evaluated the impact of a combined genomic screening program for hereditary breast and ovarian cancer, Lynch syndrome, and familial hypercholesterolemia in young adults. The program proved to be cost-effective, reducing healthcare costs and averting numerous health events, while emphasizing the need for further optimization and equitable access within public healthcare systems.

Related Keywords

Australia ,Australians ,Australian ,Monte Carlo ,Proprotein Convertase Subtilisin Kexin ,Marina Litvinova Shutterstock , ,Save Share Reprints Request Combined ,Figures Save Share Reprints Request Combined ,Breast Cancer ,Mutl Homolog ,Muts Homolog ,Low Density Lipoprotein Receptor ,Proprotein Convertase ,Kexin Type ,Genetic ,Dancer ,Familial Hypercholesterolemia ,Genes ,Enomic ,Healthcare ,Heart ,Heart Disease ,Hypercholesterolemia ,Lynch Syndrome ,Ortality ,Ovarian Cancer ,Public Health ,Research ,Surgery ,Yndrome ,